TY - JOUR
T1 - Key terms and definitions in acute porphyrias
T2 - Results of an international Delphi consensus led by the European porphyria network
AU - Members of the Acute Porphyria Expert Panel
AU - Stein, Penelope E.
AU - Edel, Yonatan
AU - Mansour, Razan
AU - Mustafa, Reem A.
AU - Sandberg, Sverre
AU - Aarsand, Aasne K.
AU - Anderson, Karl E.
AU - Badminton, Michael
AU - Balwani, Manisha
AU - Bonkovsky, Herbert L.
AU - Cappellini, Maria Domenica
AU - Cassiman, David
AU - Deybach, Jean Charles
AU - El Mikati, Ibrahim
AU - Gill, Liz
AU - Gouya, Laurent
AU - Harper, Pauline
AU - Hift, Richard
AU - Ivanova, Aneta
AU - Langendonk, Janneke G.
AU - Naik, Hetanshi
AU - Marcacci, Matteo
AU - Pischik, Elena
AU - Rees, David
AU - Sardh, Eliane
AU - Schmitt, Caroline
AU - Sonderup, Mark
AU - Stölzel, Ulrich
AU - To-Figueras, Jordi
AU - Ventura, Paolo
AU - Wang, Bruce
AU - Weiler-Normann, Christina
AU - Whatley, Sharon
AU - Wilson, Paul
N1 - Publisher Copyright:
© 2023 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
PY - 2023/7
Y1 - 2023/7
N2 - Acute porphyrias are a group of rare inherited disorders causing acute neurovisceral attacks. Many terms used frequently in the literature and clinical practice are ambiguous, which can lead to confusion in the way patients are managed, studied, and reported in clinical studies. Agreed definitions are a necessary first step in developing management guidelines and will facilitate communication of results of future clinical research. The Delphi method was used to generate consensus on key terms and definitions in acute porphyria. The process started with a brainstorming phase offered to all members of the European Porphyria Network followed by two Delphi rounds among international experts in the field of porphyria (the Acute Porphyria Expert Panel). A consensus of 75% or more was defined as the agreement threshold. A total of 63 respondents from 26 countries participated in the brainstorming phase, leading to the choice of nine terms and definitions. A total of 34 experts were invited to take part in the Delphi rounds. Seven of the initial nine terms and definitions which entered the first Delphi round achieved the threshold for agreement. Following a second Delphi round, all nine definitions achieved agreement. Agreement on the definitions for nine important terms describing acute porphyrias represents a significant step forward for the porphyria community. It will facilitate more accurate comparison of outcomes among porphyria centres and in clinical trials and provide a strong framework for developing evidence-based clinical guidelines.
AB - Acute porphyrias are a group of rare inherited disorders causing acute neurovisceral attacks. Many terms used frequently in the literature and clinical practice are ambiguous, which can lead to confusion in the way patients are managed, studied, and reported in clinical studies. Agreed definitions are a necessary first step in developing management guidelines and will facilitate communication of results of future clinical research. The Delphi method was used to generate consensus on key terms and definitions in acute porphyria. The process started with a brainstorming phase offered to all members of the European Porphyria Network followed by two Delphi rounds among international experts in the field of porphyria (the Acute Porphyria Expert Panel). A consensus of 75% or more was defined as the agreement threshold. A total of 63 respondents from 26 countries participated in the brainstorming phase, leading to the choice of nine terms and definitions. A total of 34 experts were invited to take part in the Delphi rounds. Seven of the initial nine terms and definitions which entered the first Delphi round achieved the threshold for agreement. Following a second Delphi round, all nine definitions achieved agreement. Agreement on the definitions for nine important terms describing acute porphyrias represents a significant step forward for the porphyria community. It will facilitate more accurate comparison of outcomes among porphyria centres and in clinical trials and provide a strong framework for developing evidence-based clinical guidelines.
KW - Delphi
KW - acute intermittent porphyria
KW - acute porphyria
KW - consensus
KW - hereditary coproporphyria
KW - variegate porphyria
UR - http://www.scopus.com/inward/record.url?scp=85158097268&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85158097268&partnerID=8YFLogxK
U2 - 10.1002/jimd.12612
DO - 10.1002/jimd.12612
M3 - Article
C2 - 37067064
AN - SCOPUS:85158097268
SN - 0141-8955
VL - 46
SP - 662
EP - 674
JO - Journal of Inherited Metabolic Disease
JF - Journal of Inherited Metabolic Disease
IS - 4
ER -